Fenoterol hydrobromide 非诺特罗氢溴酸盐; Th-1165a; Phenoterol hydrobromide,99.90%
产品编号:Bellancom-B0976A| CAS NO:1944-12-3| 分子式:C17H22BrNO4| 分子量:384.26
Fenoterol溴酸盐是一个β 2肾上腺素能激动剂, 用于打通呼吸道到肺部, 被归类为交感神经β2激动剂和哮喘药物。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Fenoterol hydrobromide 非诺特罗氢溴酸盐; Th-1165a; Phenoterol hydrobromide
产品介绍 | Fenoterol hydrobromide (Th-1165a) 是拟交感神经剂,是一种选择性的,具有口服活性 β2-肾上腺素受体 (β2-adrenoceptor) 激动剂。Fenoterol hydrobromide 是一种有效的支气管扩张剂,可用于与哮喘,支气管炎和其他阻塞性气道疾病相关的支气管痉挛的研究。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research. | ||||||||||||||||
体外研究 |
Fenoterol (1 μM; pre-incubated 30 minutes) treatment reduces AICAR-induced AMPK activation, NF-κB activation and TNF-α release, and also significantly downregulates the elevated phosphorylation levels of AMPK. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot Analysis
|
||||||||||||||||
体内研究 (In Vivo) |
Fenoterol (0.7 mg/kg; intraperitoneal injection; twice a day; for 3 weeks) treatment suppresses mechanical allodynia during chronic treatment. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
体内研究 |
Fenoterol (0.7 mg/kg; intraperitoneal injection; twice a day; for 3 weeks) treatment suppresses mechanical allodynia during chronic treatment. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
体内研究 |
Fenoterol (0.7 mg/kg; intraperitoneal injection; twice a day; for 3 weeks) treatment suppresses mechanical allodynia during chronic treatment. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : ≥ 100 mg/mL (260.24 mM) H2O : 25 mg/mL (65.06 mM; Need ultrasonic) * "≥" means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
参考文献 |
|
符号 |
![]() GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302 |
警示性声明 | P301 + P312 + P330 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn |
风险声明 (欧洲) | 22 |
安全声明 (欧洲) | 36 |
危险品运输编码 | UN 3249 |
WGK德国 | 3 |
RTECS号 | DO1500000 |
包装等级 | III |
海关编码 | 29225090 |

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存